Filing Details
- Accession Number:
- 0001235802-18-000184
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-11 16:42:07
- Reporting Period:
- 2018-12-11
- Accepted Time:
- 2018-12-11 16:42:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1401040 | Diamedica Therapeutics Inc. | DMAC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1759883 | A. Todd Verdoorn | 2 Carlson Parkway Suite 260 Minneapolis MN 55447 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Voting Common Shares, No Par Value Per Share | Acquisiton | 2018-12-11 | 1,000 | $4.00 | 2,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
